Evidence for interactions of endogenous peptides with the mesolimbic dopamine system
Kalivas, P.W.
Psychopharmacology Bulletin 20(3): 354-357
1984
ISSN/ISBN: 0048-5764 PMID: 6473629 Document Number: 222246
Document emailed within 1 workday
Related Documents
Kuczenski, R. 1980: Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism Journal of Pharmacology and Experimental Therapeutics 215(1): 135-142Kalivas, P. 1985: Substance P modulation of the mesolimbic dopamine system Progress in Clinical and Biological Research 192: 403-408
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Dziedzicka-Wasylewska, M.; Papp, M. 1996: Effect of chronic mild stress and prolonged treatment with imipramine on the levels of endogenous Met-enkephalin in the rat dopaminergic mesolimbic system Polish Journal of Pharmacology 48(1): 53-56
Di Chiara, G. 1991: On the preferential release of mesolimbic dopamine by amphetamine Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 5(4): 243-247
Criswell, H.; Mueller, R.A.; Breese, G.R. 1988: Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine Journal of Pharmacology and Experimental Therapeutics 244(2): 493-500
Bidzińska, B.; Jedrzejuk, D. 1995: Function of endogenous opioid peptides and sex steroids at the level of the central nervous system Postepy Higieny i Medycyny Doswiadczalnej 49(4): 523-530
Phillips, M.I.; Weyhenmeyer, J.; Felix, D.; Ganten, D.; Hoffman, W.E. 1979: Evidence for an endogenous brain renin-angiotensin system Federation Proceedings 38(9): 2260-2266
Morelli, A.; Narducci, F.; Camardella, G.; Pelli, M.A.; Floridi, A.; Nenci, G.G. 1977: Dopamine uptake by platelets in hepatic encephalopathy; evidence for a possible depletion of brain dopamine Acta Hepato-Gastroenterologica 24(6): 405-410
Katzman, R.; Makman, M.H.; Ahn, H.S.; Mishra, R.K.; Gardner, E. 1977: Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors Transactions of the American Neurological Association 102: 76-79
Wang, H.Y.; Undie, A.S.; Friedman, E. 1995: Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation Molecular Pharmacology 48(6): 988-994
Arushanian, E.B. 1977: Mesolimbic system of the brain and its participation in the action of psychotropic substances (a review of the literature) Farmakologiia i Toksikologiia 40(5): 623-630
Ivanova, V.T.; Karelin, A.A.; Mikhaleva, I.I.; Vas'kovskiĭ, B.V.; Sviriaev, V.I.; Nazimov, I.V. 1992: Isolation, structure and properties of new endogenous peptides Bioorganicheskaia Khimiia 18(10-11): 1271-1311
Kunsdorf-Wnuk, A. 1980: Opiate receptors and morphine-like endogenous peptides Polski Tygodnik Lekarski 35(35): 1361-1363
Goldberg, L.I. 1974: Dopamine--clinical uses of an endogenous catecholamine New England Journal of Medicine 291(14): 707-710
Przewłocki, R. 1984: Some aspects of physiology and pharmacology of endogenous opioid peptides Polish Journal of Pharmacology and Pharmacy 36(2-3): 137-158
Goetzl, E.J.; Chernov-Rogan, T.; Cooke, M.P.; Renold, F.; Payan, D.G. 1985: Endogenous somatostatin-like peptides of rat basophilic leukemia cells Journal of Immunology 135(4): 2707-2712
Waluś, K.M. 1978: Discovery and biological role of endogenous morphinomimetic peptides Przeglad Lekarski 35(12): 891-894
Castells Molina, S.; Rodríguez Méndez, S.A. 1988: The role of dopamine in the gastrointestinal tract and its relation to intestinal peptides Medicina Clinica 90(1): 28-32
Hiller, J.M. 1981: Interactions of opioid peptides with their receptors Progress in Clinical and Biological Research 68: 29-52